I am not sure if anyone has taken a look at Aurx, but to date they
have the most promising clinical studies and might go under if they do
not get enough people to signup for their third phase trials. The
companies drug is based on work performed by a researcher at the
university of baltimore.
http://pharmacology.umaryland.edu/laurelian/

Here is a link to the phase I/II clinical trials.

http://www.centerwatch.com/patient/nmtresults/nmt021014.html

So, please signup for the clinical trials at:
www.aurx.com

You can always change your mind later if you do not want to go through
with this, but they need a couple thousand signups by the end of the
month to secure another round of financing.
-Billy

p.s. I do not work for them, I just believe in the progression of
medicine..